141 related articles for article (PubMed ID: 9779073)
21. Detection of bone metastases in cancer patients by 18F-fluoride and 18F-fluorodeoxyglucose positron emission tomography.
Cook GJ; Fogelman I
Q J Nucl Med; 2001 Mar; 45(1):47-52. PubMed ID: 11456375
[TBL] [Abstract][Full Text] [Related]
22. Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans.
Sheth S; Colletti PM
Clin Nucl Med; 2012 May; 37(5):e110-6. PubMed ID: 22475920
[TBL] [Abstract][Full Text] [Related]
23. Fluorine-18-FDG PET in Paget's disease of bone.
Cook GJ; Maisey MN; Fogelman I
J Nucl Med; 1997 Sep; 38(9):1495-7. PubMed ID: 9293817
[TBL] [Abstract][Full Text] [Related]
24. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
Nagarajah J; Dannat T; Hartung V; Bockisch A; Rosenbaum-Krumme S
Nuklearmedizin; 2012; 51(3):84-7. PubMed ID: 22366817
[TBL] [Abstract][Full Text] [Related]
25. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR
Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282
[TBL] [Abstract][Full Text] [Related]
26. The role of positron emission tomography in skeletal disease.
Cook GJ; Fogelman I
Semin Nucl Med; 2001 Jan; 31(1):50-61. PubMed ID: 11200205
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of malignant and degenerative bone lesions using dexamethasone interventional 3- and 24-hour bone scintigraphy.
Bhatnagar A; Mondal A; Kashyap R; Sharma RK; Sharma R; Chakravarty SK; Bihari V; Sawroop K; Chopra MK; Soni NL
Eur J Nucl Med; 1994 Jul; 21(7):609-14. PubMed ID: 7957346
[TBL] [Abstract][Full Text] [Related]
28. Atlas of Extraosseous Findings Detected by 18F-NaF PET/CT Bone Scan.
Woodhead GJ; Avery RJ; Kuo PH
Clin Nucl Med; 2017 Dec; 42(12):930-938. PubMed ID: 29036001
[TBL] [Abstract][Full Text] [Related]
29. [Clinical usefulness of 201Tl-chloride scintigraphy for the evaluation of metastatic bone lesions].
Fukui A; Kawamura M; Kataoka M; Fujii T; Yamamoto K; Yoshioka S; Ikezoe J
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jan; 58(1):25-33. PubMed ID: 9493430
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of solitary rib hot spots on bone scans in patients with extraskeletal cancer: correlation with other clinical manifestations.
Wu PS; Chiu NT; Lee BF; Yao WJ; W Chen HH
Clin Nucl Med; 2002 Aug; 27(8):567-71. PubMed ID: 12170001
[TBL] [Abstract][Full Text] [Related]
31. [Whole-body bone scintigraphy in the diagnosis and follow-up of the evolution of breast cancer].
Muşat E; Stefănescu C; Rusu V
Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):163-9. PubMed ID: 10756905
[TBL] [Abstract][Full Text] [Related]
32. Elevated 99mTc-MDP and 18F-NaF Uptake in a Bladder Stone.
Zou Y; Chen Y; Huang Z; Cai L; Shao F
Clin Nucl Med; 2016 Sep; 41(9):732-3. PubMed ID: 27355851
[TBL] [Abstract][Full Text] [Related]
33. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose.
Dehdashti F; Siegel BA; Griffeth LK; Fusselman MJ; Trask DD; McGuire AH; McGuire DJ
Radiology; 1996 Jul; 200(1):243-7. PubMed ID: 8657920
[TBL] [Abstract][Full Text] [Related]
34. Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain.
Lim R; Fahey FH; Drubach LA; Connolly LP; Treves ST
J Pediatr Orthop; 2007; 27(3):277-82. PubMed ID: 17414009
[TBL] [Abstract][Full Text] [Related]
35. Bone SPECT.
Collier BD; Hellman RS; Krasnow AZ
Semin Nucl Med; 1987 Jul; 17(3):247-66. PubMed ID: 3303342
[TBL] [Abstract][Full Text] [Related]
36. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
[TBL] [Abstract][Full Text] [Related]
38. [Use of bone SPECT of the dorsolumbar spine in oncological patients with suspected bone metastases].
Fuster D; Pons F; Laterza C; Setoain FJ; Herranz R; Setoain J
Rev Esp Med Nucl; 1998; 17(4):278-82. PubMed ID: 9721344
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of a utility of 18F-fluoride ion PET as a systemic bony lesion search examination and comparison with bone scintigraphy].
Uno K; Inoue T; Ido T; Endo K; Kubo A; Kusakabe K; Takeda K; Murakami K; Yamaguchi K; Yoshikawa K;
Kaku Igaku; 2009 Jun; 46(2):103-6. PubMed ID: 19637821
[No Abstract] [Full Text] [Related]
40. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG.
Cook GJ; Houston S; Barrington SF; Fogelman I
J Nucl Med; 1998 Jan; 39(1):99-103. PubMed ID: 9443745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
